English
Back
Download
Log in to access Online Inquiry
Back to the Top

Investors expect limited growth for Jiangsu Nhwa Pharmaceuti...

Investors expect limited growth for Jiangsu Nhwa Pharmaceutical, reflected in a low P/E ratio. The inferior earnings outlook compared to the market justifies this lowered P/E. Dismal earnings could further hinder the share price increase.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more
Translate
Report
1333 Views
Comment
Sign in to post a comment